Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · INTELLIGENT BIO SOLUTIONS INC. (INBS)

Intelligent Bio Solutions reports 3,316,803 shares outstanding as of September 10, 2026

Neutral Impact 1 of 5 shareholder Written later

Intelligent Bio Solutions disclosed an updated count of its common stock outstanding, reaching 3,316,803 shares as of the close of business on September 10, 2026. The increase reflects the exercise of prefunded warrants for 285,000 shares and the issuance of 4,333 restricted shares under a previously disclosed investor relations advisory agreement. The update is administrative and does not report financial results or guidance.

Key points

  • Total common shares outstanding as of September 10, 2026: 3,316,803
  • Prefunded warrants exercised for 285,000 shares of common stock
  • 4,333 shares of restricted common stock issued under the February 29, 2024 Investor Relations and Corporate Development Advisory Agreement

The filing

CompanyINTELLIGENT BIO SOLUTIONS INC. (INBS)
Form8-K, current report
Filed with the SECSep 11, 2026, 5:00 PM ET
Accession number0001493152-26-042411

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.